Zusammenfassung
Nichtmaligne Erkrankungen weisen zahlreiche Merkmale auf, die berechtigten Anlass zu ihrer Behandlung geben. Sie können invasiv und aggressiv wachsen ohne Metastasen zu setzen wie z.B. beim Desmoid ; sie können kosmetisch entstellend und funktionell sehr störend sein wie beim Keloid oder der endokrinen Orbitopathie; teilweise können sie sogar lebensbedrohlich sein, z. B. beim therapierefraktären Hämangiom der Leber (Kasabach-Merritt-Syndrom ) oder dem juvenilen Angiofibrom im Gesichtsbereich bei Kindern und Jugendlichen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Zu Allgemeine Einführung und Evidenzbasierte Anwendung
Broerse JJ, Snijders-Keilholz A, Jansen JTM et al. (1999) Assessment of carcinogenic risk for treatment of Graves’ ophthalmopathy in dependence on age and irradiation geometry. Radiother Oncol 53:205–208
Bureau of Radiological Health (1977) A Review of the use of ionizing radiation for the treatment of benign disease, vol 1, pp 1–2. Rockville, MD, US Department of Health, Education and Welfare
Hess F (1980) Strahlentherapie gutartiger Erkrankungen. In: Scherer E (Hrsg) Strahlentherapie – Radiologische Onkologie, Springer, Berlin Heidelberg New York Tokio, S 354–369
ICRP Publication No. 60 (1991) 1990 Recommendations of the International Commission on Radiological Protection. Annals of the ICRP, vol 21, 1–3, Pergamon Press, Oxford
Jansen JTM, Broerse J, Zoetelief J, Klein C, Seegenschmiedt MH (2001) Assessment of Carcinogenic Risk in the Treatment of Benign Disease of Knee and Shoulder Joint. In: Seegenschmiedt MH, Makoski HB (Hrsg) 15. Kolloquium Radioonkologie/Strahlentherapie, Radiotherapie bei gutartigen Erkrankungen. Diplodocus, Altenberge, pp 13–15
Kramer S, Herring DF (1976) The patterns of care study: a nationwide evaluation of the practice of radiation therapy in cancer management in radiation therapy. Int J Radiat Oncol Biol Phys 1:1231–1236
Kramer S (1977) The study of the patterns of care in radiation therapy. Cancer 39:780–787
Leer JWH, van Houtte P, Davelaar J (1998) Indications and treatment schedules for irradiation of benign diseases: a survey. Radiother Oncol 48:249–257
Makoski HB (1997) Gutartige Erkrankungen (Kapitel 11). In: Sack H, Scherer E (Hrsg) Radiologische Onkologie (3. Aufl). Springer, Berlin Heidelberg New York Tokio, pp 293–311
Micke O, Seegenschmiedt MH (2002) The German Working Group guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 52:496–513
Order EO, Donaldson SS (eds) (1998) Radiation therapy of benign diseases. 2nd edn. Springer, Berlin Heidelberg New York Tokio
Seegenschmiedt MH, Katalinic A, Makoski H et al. (2000) Radiation therapy for benign diseases: patterns of care study in Germany. Int J Radiat Oncol Biol Phys 47:195–202
Seegenschmiedt MH, Makoski HB, Micke O, German Cooperative Group Radiotherapy for Benign Diseases (2001) Benign diseases: Radiation prophylaxis for heterotopic ossification about the hip joint – a multi-center study. Int J Radiat Oncol Biol Phys 51:756–765
Seegenschmiedt MH, Micke O, Willich N (2004) Radiation therapy for non-malignant diseases in Germany – Current concepts and future perspectives. Strahlenther Onkol 180:718–730
Trott KR (1994) Therapeutic effects of low radiation doses. Strahlenther Oncol 170:1–12
Zu Strahlenbiologische Voraussetzungen
Behrends U, Peter RU, Hintermeier-Knabe R et al. (1994) Ionising radiation induces human intercellular adhesion molecule 1 in vitro. J Invest Dermatol 103:726–730
Hildebrandt G, Seed MP, Freemantle CN et al. (1998 a) Effects of low dose ionizing radiation on murine chronic granulomatous tissue. Strahlenther Onkol 174:580–588
Hildebrandt G, Seed MP, Freemantle CN et al. (1998 b) Mechanisms of the anti-inflammatory activity of low-dose radiation therapy. Int J Radiat Biol 74:367–378
Hildebrandt G, Jahns J, Hindemith M et al. (2000) Effects of low dose radiation therapy on adjuvant induced arthritis in rats. Int J Radiat Biol 76:1143–1153
Hildebrandt G, Magiorella, Rödel F, Rödel V, Willis D, Trott KR (2002) Mononuclear cell adhesion and cell adhesion molecule liberation after X-irradiation of activated endothelial cells in vitro. Int J Radiat Biol 78:315–325
Hildebrandt G, Radlingmayr A, Rosenthal S et al. (2003) Lowdose radiotherapy (LD-RT) and the modulation of iNOS expression in adjuvant-induced arthritis in rats. Int J Radiat Biol 79:993–1001
Hosoi Y, Miyachi H, Matsumoto Y et al. (2001) Induction of interleukin-1beta and interleukin-6mRNA by low doses of ionizing radiation in macrophages. Int J Cancer 96:270–276
Hopewell JW, Robbins MEC, Van den Aardweg GJMJ et al. (1993) The modulation of radiation-induced damage to pig skin by essential fatt acids. Brit J Cancer 58:1–7
ICRP Publication 60 (1991) Recommendations of the International Commission on Radiological Protection. Annals of the ICRP 21:1–3. Pergamon Press, Oxford
Kern PM, Keilholz L, Forster C et al. (1999) In vitro apoptosis in peripheral blood mononuclear cells induced by low-dose radiotherapy displays a discontinuous dose-dependance. Int J Radiat Biol 75:995–1003
Kern PM, Keilholz L, Forster C et al. (2000) Low-dose radiotherapy selectively reduces adhesion of peripheral blood mononuclear cells to endothelium in vitro. Radiother Oncol 54:273–282
Magiorella L (1985) The effect of low doses of X-rays on cell adhesion molecule expression in stimulated E.A.hy.926 endothelial cells. J Immunol 135:1119–1125
Micke P, Blaukat A, Micke O (2003) Effect of Cobalt-60 irradiation on bradykinin B2 receptor expression on human HF-15 cells. Ex Cli Journal 2:52–57
O’Brien-Ladner A, Nelson ME, Kimler BF, Wesselius L (1993) Release of interleukin 1 by human alveolar makrophages after in vitro irradiation. Radiat Res 136:37–41
Rodemann HP, Bamberg M (1985) Cellular basis of radiationinduced fibrosis. Radiother Oncol 35:83–90
Rödel F, Kamprad F, Sauer R, Hildebrandt G (2002) Funktionelle und molekulare Aspekte der anti-inflammatorischen Wirkung niedrig dosierter Radiotherapie. Strahlenther Onkol 178:1–9
Rödel F, Kley N, Beuscher HU et al. (2002) Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion. Int J Radiat Biol 78:711–719
Rödel F, Schaller U, Schultze-Mosgau S et al. (2004) The induction of TGF-beta(1)-and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation. Strahlenther Onkol 180:194–200
Rubin, P, Soni A, Williams JP (1999) The molecular and cellular basis for the radiation treatment of benign proliferative diseases. Sem Radiat Oncol 9:203–214
Schaue D, Marples B, Trott KR (2002) The effects of low-dose x-irradiation on the oxidative burst in stimulated makrophages. Int J Radiat Biol 78:567–576
Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW (1991) Regulation of tumor necrosis factor gene expression by ionising radiation in human myeloid leikemia cells and peripheral blood monocytes. J Clin Invest 87:1794–1797
Sokoloff N (1898) Röntgenstrahlen gegen Gelenkrheumatismus. Fortschr Röntgenstr 1:209–213
Trott KR (1994) Therapeutic effects of low radiation doses. Strahlenther Oncol 170:1–12
Trott KR, Parker R, Seed MP et al. (1995) The effect of x-rays on experimental arthritis in the rat. Strahlenther Onkol 171:534–538
Trott K-R, Kamprad F (1999) Radiobiological mechanisms of anti-inflammatory radiotherapy. Radiother Oncol 51:197–203
Vieten H (1977) Neurovegetative Wirkungen der Strahlentherapie. Grundlagen und Möglichkeiten der radiologischen Funktionstherapie. Die Reaktion des vegetativen Nervensystems auf ionisierende Strahlen. In: Sturm A, Birkmayer W (Hrsg) Klinische Pathologie des vegetativen Nervensystems. Fischer, Stuttgart New York, S 1531–1547
Von Pannewitz G (1970) Degenerative Erkrankungen. In: Zuppinger A, Ruckensteiner E (Hrsg) Handbuch der medizinischen Radiologie. Springer, Berlin Heidelberg New York Tokio, S 96–98
Von Wangenheim KH, Petersen HP, Schwenke K (1995) A major component of radiation action: interference with intracellular control of differentiation. Int J Radiat Biol 68:369–388
Zu Meningeom
Ciric I, Rosenblatt S (2001) Suprasellar meningiomas. Neurosurg 49:1372–1377
Debus J, Wuendrich M, Pirzkall A et al. (2001) High efficacy of fractionated stereotactic radiotherapy of large skull base meningiomas: Long-term results. J Clin Oncol 19:3547–3553
Engenhart R, Kimmig BN, Hover KH et al. (1990) Stereotactic single high dose radiation therapy of benign intracranial meningiomas. Int J Radiat Oncol Biol Phys 19:1021–1026
Goldsmith BJ, Wara WM, Wilson CB, Larson D (1994) Prospective irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967–1990. J Neurosurg 80:195–201
Goodwin JW, Crowley J, Eyre HJ et al. (1993) A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: A Southwest Oncology Group Study. J Neurooncol 15:75–77
Grunberg S, Weiss M, Spitz I et al. (1991) Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74:861–886
Gudjonsson O, Blomquist E, Nyberg G et al. (1999) Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir (Wien) 141:933–940
Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD (1999) Long-term outcomes after meningioma radiosurgery: Physician and patient perspectives. J Neurosurg 91:44–50
Kyritsis AP (1996) Chemotherapy for meningiomas. J Neurooncol 29:269–272
Mathiesen T, Lindquist C, Kihlstrom L (1996) Recurrence of cranial base meningiomas. Neurosurg 39:2–7
Milosevic M, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ (1996) Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34:817–822
Muthukumar N, Kondziolka D, Lunsford LD, Flickinger JC (1998) Stereotactic radiosurgery for tentorial meningiomas. Acta Neurochir (Wien) 140:315–320
Nutting C, Brada M, Brazil L et al. (1999) Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg 90:823–827
Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39
Stewart DJ, Dahrouge S, Wee M, Aitken S, Hugenholtz H (1995) Intraarterial cisplatin plus intravenous doxorubicin for inoperable recurrent meningiomas. J Neurooncol 24:189–194
Taylor B, Marcus R, Friedman W, Ballinger W, Million R (1988) The meningioma controvery: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:299–304
Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP (2001) Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 49:99–105
Wenkel E, Thornton AF, Finkelstein D et al. (2000) Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 48:1363–1370
Zu Hypophysenadenom
Becker G et al. (2002) Radiation Therapy in the multimodal treatment approach of pituitary adenoma. Strahlenth Onkol 4:173–86
Engenhart-Cabilic R et al. (Hrsg) (1998) Leitlinien zur Strahlentherapie von Hypophysenadenomen AG Hypophyse und Hypophysentumore der Deutschen Gesellschaft für Endokrinologie (DGE), der Deutschen Gesellschaft für Radioonkologie (DEGRO), der Deutschen Gesellschaft für Neurochirurgie, der AG Radioonkologie (ARO) und der AG Neuroonkologie (NOA) der Deutschen Krebsgesellschaft
Grabenbauer GG et al. (1996) Hormoninaktive Hypophysenadenome: Resultate und Spätfolgen nach Operation und Radiotherapie. Strahlenther Onkol 172:193–197
Grigsby PW et al. (1988) Results of surgery and irradiation and or irradiation alone for pituitary adenomas. J Neurooncol 6:129–134
Gingsby PW, Smpson JR, Emami BN et al. (1989) Prognostic factors and results of surgery and postoperative radiotherapy in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys 16:1411–1417
Isobe K et al. (2000) Postoperative radiation therapy for pituitary adenoma. J Neurooncol 48:135–140
Levy RP et al. (1996) Stereotactic helium-ion irradiation for Cushing’s disease, prolactinoma, and non-secreting adenoma – 36 years experience at Lawrence Berkeley Laboratory. Radiosurgery 1:66–74
Milker-Zabel S et al. (2001) Fractionated stereotacally guided radiosurgery and radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 50:1279–1286
McCord MW et al. (1997) Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 39:437–444
Quabbe HJ, Fahlbusch R, Von zur Mühlen A, Müller OA, Schulte HM, Von Werder K, Willig R (1997) Rationelle Therapie in der Endokrinologie. Herausgegeben von der Deutschen Gesellschaft für Endokrinologie. In: Ziegler R, Landgraf R, Müller OA, Von zur Mühlen A (Redaktion) Hypothalamus und Hypophyse. Thieme, Stuttgart, S 1–33
Shaw E et al. (1995) Radiation Therapy Oncology Group: Radiosurgery quality assurance Guidelines. Int J Radiat Oncol Biol Phys 33:301–307
Zierhut D et al. (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314
Zu Kraniopharyngeom
Becker G, Kortmann RD, Skaley M et al. (1999) The role of radiotherapy in the treatment of craniopharyngioma – indications, results, side effects. Front Radiat Ther Oncol 33:100–113
Bloom HJ, Glees J, Bell J (1990) The treatment and long-term prognosis of children with intracranial tumors: A study of 610 cases, 1950–1981. Int J Radiat Oncol Biol Phys 18:723–745
DeVile CJ, Grant DB, Hayward RD et al. (1996) Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 75:108–114
Habrand JL, Ganry O, Couanet D et al. (1999) The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 44:255–263
Hoffmann HJ, DeSilva M, Humphreys RP et al. (1992) Aggressive surgical management of cranio-pharyngiomas in children. J Neurosurg 76:47–52
Rajan B, Ashley S, Gorman C et al. (1993) Craniopharyngioma – long-term results following limited surgery and radiotherapy. Radiother Oncol 26:1–10
Sanford RA, Muhlbauer MS (1991) Craniopharyngioma in children. Neurol Clin 9:453–465
Sanford RA (1994) Craniopharyngioma: Results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg 21 (Suppl 1):39–43
Sung DI, Chang CH, Harisiadis L et al. (1981) Treatment results of craniopharyngiomas. Cancer 47:847–852
Schulz-Ertner D, Frank C, Herfarth KK et al. (2002) Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 54:1114–1120
Tomita T, McLone D (1993) Radical resection of childhood craniopharyngiomas. Pediatr Neurosurg 19:6–14
Zu Akustikusneurinom
Andrews DW, Suarez O, Goldmann HW et al. (2001) Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 50:1265–1278
Flickinger JC, Kondziolka D, Lunsford L (1996) Dose and diameter relationships for facial, trigeminal, and acoustic neuropathies following acoustic neuroma radiosurgery. Radiother Oncol 41:215–219
Flickinger JC, Kondziolka D, Niranjan A, Lunsford LD (2001) Results of acoustic neuroma radiosurgery: An analysis of 5 years’ experience using current methods. J Neurosurg 94:1–6
Foote KD, Friedman WA, Buatti JM, Meeks SL, Bova FJ, Kubilis PS (2001) Analysis of risk factors associated with radiosurgery for vestibular schwannoma. J Neurosurg 95:440–449
Fuss M, Debus J, Lohr F et al. (2000) Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys 48:1381–1387
Iwai Y, Yamanaka K, Shiotani M, Uyama T (2003) Radiosurgery for acoustic neuromas: results of low-dose treatment. Neurosurgery 53:282–287
Karpinos M, Teh BS, Zeck O et al. (2002) Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys 54:1410–1421
Linskey ME, Martinez AJ, Kondziolka D et al. (1993) The radiobiology of human acoustic schwannoma xenografts after stereotactic radiosurgery evaluated in the subrenal capsule of athymic mice. J Neurosurg 78:645–653
Meijer OW, Vandertop WP, Baayen JC, Slotman BJ (2003) Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study. Int J Radiat Oncol Biol Phys 56:1390–1396
Niranjan A, Lunsford LD, Flickinger JC et al. (1999) Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery. Neurosurgery 45:753–762
Perks JR, St George EJ, El Hamri K et al. (2003) Stereotactic radiosurgery XVI: Isodosimetric comparison of photon stereotactic radiosurgery techniques (gamma knife vs. micromultileaf collimator linear accelerator) for acoustic neuroma – and potential clinical importance. Int J Radiat Oncol Biol Phys 57:1450–1459
Petit JH, Hudes RS, Chen TT et al. (2001) Reduced-dose radiosurgery for vestibular schwannomas. Neurosurgery 49:1299–1306
Regis J, Pellet W, Delsanti C et al. (2002) Functional outcome after gamma knife surgery or micro-surgery for vestibular schwannomas. J Neurosurg 97:1091–1100
Rowe JG, Radatz MW, Walton L et al. (2003) Gamma knife stereotactic radiosurgery for unilateral acoustic tumors. J Neurol Neurosurg Psychiatry 74:1536–1542
Sakamoto T, Shirato H, Takeichi N et al. (2001) Annual rate of hearing loss falls after fractionated stereotactic irradiation for vestibular schwannoma. Radiother Oncol 60:45–48
Samii M, Matthies C (1997 a) Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurg 40:11–21
Samii M, Matthies C (1997 b) Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumor resections. Neurosurg 40:248–260
Samii M, Matthies C (1997 c) Management of 1000 vestibular schwannomas (acoustic neuromas): the facial nerve preservation and restitution of function. Neurosurg 40:684–694
Sawamura Y, Shirato H, Sakamoto T et al. (2003) Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption. J Neurosurg 99:685–692
Seo Y, Fukuoka S, Nakagawara J et al. (1996) Effect of gamma knife radiosurgery on acoustic neurinomas. Stereotact Funct Neurosurg 66 (Suppl 1):93–102
Shirato H, Sakamoto T, Takeichi N et al. (2000) Fractionated stereotactic radiotherapy for vestibular schwannoma (VS): a comparison between cystic-type and solid-type VS. Int J Radiat Oncol Biol Phys 48:1395–1401
Tos M, Thomsen J (1992) Proposal of classification of tumor size in acoustic neuroma surgery. In: Tos M, Thomsen J (eds) Proceedings of the first international conference on acoustic neuroma. Kugler, Amsterdam
Williams JA (2002) Fractionated stereotactic radiotherapy for acoustic neuromas. Int J Radiat Oncol Biol Phys 54:500–504
Yamakami I, Uchino Y, Kobayashi E et al. (2003) Conservative management, gamma-knife radiosurgery, and microsurgery for acoustic neurinomas: a systematic review of outcome and risk of three therapeutic options. Neurol Res 25:682–690
Zu Arteriovenöse Malformationen
Chang JH, Chang JW, Park YG, Chung S (2000) Factors related to complete occlusion of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg 93 (Suppl 3):96–101
Colombo F, Pozza F, Chierego G et al. (1994) Linear accelerator radiosurgery of cerebral arteriovenous malformations: an update. Neurosurgery 34:14–21
Deruty R, Pelissou-Guyotat I, Amat D et al. (1996) Complications after multidisciplinary treatment of cerebral arteriovenous malformations. Acta Neurochir (Wien) 138:119–131
Deruty R, Pelissou-Guyotat I, Morel C et al. (1998) Reflections on the management of cerebral arteriovenous malformations. Surg Neurol 50:245–255
Dion JE, Mathis JM (1994) Cranial arteriovenous malformations: The role of embolization and stereotactic surgery. Neurosurg Clin North Am 5:459–474
Engenhart R, Wowra B, Debus J et al. (1994) The role of high-dose, single-fraction irradiation in small and large intracranial AVMs. Int J Radiat Oncol Biol Phys 30:521–529
Fajardo LF (1992) Morphology of radiation effects on normal tissue. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology 2nd ed. Lippincott, Philadelphia New York London Hagerstown, pp114–123
Fleetwood IG, Marcellus ML, Levy RP et al. (2003) Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg 98:747–750
Flickinger JC, Schell MC, Larson DA (1990) Estimation of complications for linear accelerator radio-surgery with the integrated logistic formula. Int J Radiat Oncol Biol Phys 19:143–148
Flickinger JC, Pollock BE, Kondziolka D et al. (1996) LD A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radial Oncol Biol Phys 36:873–879
Flickinger JC, Kondziolka D, Maitz AH et al. (1998) Analysis of neurological sequelae from radio-surgery of AVMs: how location affects outcome. Int J Radiat Oncol Biol Phys 40:273–278
Flickinger JC, Kondziolka D, Lunsford LD et al. (1999) A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys 44:67–74
Flickinger JC, Kondziolka D, Maitz AH et al. (2002) An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration. Radiother Oncol 63:347–354
Friedman WA, Bova FJ, Bollampally S et al. (2003) Analysis of factors predictive of success or complications in arteriovenous malformation radiosurgery. Neurosurgery 52:296–308
Graf CJ, Perret GE, Torner JC (1983) Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 58:331–337
Han PP, Ponce FA, Spetzler RF (2003) Intention-to-treat analysis of Spetzler-Martin grades IV and V AVMs: natural history and treatment paradigm. J Neurosurg 98:3–7
Kocher M, Voges J, Mueller R-P et al. (1998) Linac radiosurgery for patients with a limited number of brain metastases. J Radiosurg 1:9–15
Laing RW, Childs J, Brada M (1992) Failure of conventionally fractionated radiotherapy to decrease the risk of hemorrhage in inoperable AVMs. Neurosurgery 30:872–875
Lindquist C, Steiner L, Blomgren H et al. (1986) Stereotactic radiation therapy of intracranial arteriovenous malformations. Acta Radiol 368 (Suppl):610–613
Miyawaki L, Dowd C, Wara W et al. (1999) Five year results of linac radiosurgery for arteriovenous malformations: outcome for large avms. Int J Radiat Oncol Biol Phys 44:1089–1106
Nakata H, Yoshimine T, Murasawa A et al. (1995) Early bloodbrain barrier dis-ruption after high-dose single-fraction irradiation in rats. Acta Neurochir (Wien) 136:82–86
Pollock BE, Kline RW, Stafford SL (2000) The rationale and technique of staged-volume arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys 48:817–824
Poulsen MG (1987) Arteriovenous malformation – a summary of 6 cases treated with radiation therapy. Int J Radiat Oncol Biol Phys 13:1553–1557
Schlienger M, Atlan D, Lefkopoulos et al. (2000) Linac radiosurgery for cerebral arteriovenous malformations: results in 169 patients. Int J Radiat Oncol Biol Phys 46:1135–1142
Shin M, Kawamoto S, Kurita H et al. (2002) Retrospective analysis of a 10-year experience of stereo-tactic radiosurgery for AVMs in children and adolescents. J Neurosurg 97:779–784
Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65:476–483
Stapf C, Mast H, Sciacca RR et al. (2003) The New York Islands AVM Study: design, study progress, and initial results. Stroke 34:29–33
Stefani MA, Porter PJ, terBrugge KG et al. (2002) Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 33:1220–1224
Steiner L, Lindquist C, Adler JR et al. (1992) Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg 77:1–8
van der Kogel AJ (1991) Central nervous system radiation injury in small animal models. In: Gutin PH, Leibel SA, Sheline GE (eds) Radiation injury to the nervous system. Raven press, New York, pp 91–112
Voges J, Treuer H, Sturm V et al. (1996) Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys 36:1055–1063
Voges J, Treuer H, Lehrke R et al. (1997) Risk analysis of LINAC radiosurgery in patients with arteriovenous malformation (AVM). Acta Neurochir (Wien) 68 (Suppl):118–123
Wilms M, Kocher M, Makoski H-B et al. (2003) Langzeitergebnisse der semistereotaktischen konventionell fraktionierten Strahlenbehandlung arterio-venöser Malformationen des Gehirns. Strahlenther Onkol 179 (Suppl):69
Wolbers JG, Mol HC, Kralendonk JH et al. (1999) Stereotactic radiosurgery with adjusted linear accelerator for cerebral arteriovenous malformations: preliminary results in the Netherlands. Ned Tijdschr Geneeskd 143:1215–1221
Zu Chordome
Austin-Seymour M, Munzenrider J, Goitein M et al. (1989) Fractionated proton radiation therapy for chordomas and low grade chondrosarcomas of the base of skull. J Neurosurg 70:13–17
Castro JR, Linstadt DE, Bahary J-P et al. (1994) Experience in charged particle irradiation of tumors of the skull base: 1977–1992. Int J Radiat Oncol Biol Phys 29:647–655
Catton C, O’Sullivan B, Bell R et al. (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67–72
Debus J, Schulz-Ertner D, Schad L et al. (2000) Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 47:591–596
Fuller DB, Bloom JG (1988) Radiotherapy for chordoma. Int J Radiat Oncol Biol Phys 15:331–339
Hug EB, Loredo LN, Slater JD et al. (1999) Proton radiation therapy for chordomas and chondro-sarcomas of the skull base. J Neurosurg 91:432–439
Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175 (Suppl II):57–63
Muthukumar N, Kondziolka D, Lunsford LD et al. (1998) Stereotactic radiosurgery for chordoma and chondrosarcoma: further experience. Int J Radiat Oncol Biol Phys 41:387–392
Noel G, Habrand JL, Jauffret E et al. (2003) Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol 179:241–248
O’Connell JX, Laurette GR, Liebsch NJ et al. (1994) Base of skull chordoma. Cancer 74:2261–2267
Rich TA, Schiller A, Suit HD et al. (1985) Clinical and pathologic review of 48 cases of chordoma. Cancer 56:182–187
Romero J, Cardenes H, la Torre A et al. (1993) Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 29:27–32
Schulz-Ertner D, Nikoghosyan A, Thilmann C et al. (2003) Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Strahlenther Onkol 179:598–605
Zorlu F, Gurkaynak M, Yildiz F et al. (2000) Conventional external radiotherapy in the management of clivus chordomas with overt residual disease. Neurol Sci 21:203–207
Zu Glomustumor bzw. Chemodektom
Cole JM, Beiler D (1994) Long-term results of treatment of glomus jugulare and glomus vagale tumors with radiotherapy. Laryngoscope 104:1461 ff
Cummings BJ, Beale FA, Garrett PG et al. (1984) The treatment of glomus tumors in the temporal bone by megavoltage radiation. Cancer 53:2635 ff
Eustacchio S, Trummer M, Unger F, et al. (2002) The role of gamma knife radiosurgery in the management of glomus jugulare tumors. Acta Neurochir (Suppl) 84:91 ff
Fisch U, Mattox P (1988) Microsurgery of the skull base. Thieme, New York
Foote RL, Pollock BE, Gorman DA et al. (2002) Glomus jugulare tumor: tumor control and complication after stereotactic radiosurgery. Head Neck 24:332 ff
Hinerman RW, Mendenhall WM, Amdur RJ et al. (2001) Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body and glomus vagale. Head Neck 23:363 ff
Jackson AW, Koshiba R (1974) Treatment of glomus jugulare tumors by radiotherapy. Proc R Soc Med 67:267 ff
Kim JA, Elkon D, Lim ML, Constable WC (1980) Optimum dose of radiotherapy for chemodectomas in the middle ear. Int J Radiat Oncol Biol Phys 6:815 ff
Lalwani AK, Jackler RK, Gutin PH (1993) Lethal fibrosarcoma complicating radiation therapy for bening glomus jugulare tumor. Am J Otol 14:398 ff
Lim M, Gibbs IC, Adler JR et al. (2003) The efficacy of linear accelerator stereotactic radiosurgery in treating glomus jugulare tumors. Technol Cancer Res Treat 2:261 ff
Liscak R, Vladyka V, Wowra B et al. (1999) Gamma knife radiosurgery of the glomus jugulare tumor – early multicentre experience. Acta Neurochir 141:1141 ff
Maarouf M, Voges J, Landwehr P et al. (2003) Stereotactic linear accelerator based radiosurgery for the treatment of patients with glomus jugulare tumors. Cancer 97:1093 ff
Million RR, Cassisi NJ, Mancuso AA, Stringer SP (1994) Chemodectomas (glomus body tumors). In: Million RR, Cassisi NJ (eds) Management of head and neck cancer. A multidisciplinary approach. 2nd edn. Philadelphia, pp 765–783
Pohl F, Thile W, Koelbl O, Flentje M (2003) Retrospective Analyse von 12 Patienten mit Glomus jugulare Tumoren nach Radiotherapie. Strahlenther Onkol 179:3 ff
Powell S Peters N, Hartmer C (1992) Chemodectoma of the head and neck: Results of treatment in 84 patients. Int J Radiat Oncol Biol Phys 22:919 ff
Sharma PD, Johnson AP, Whitton AC (1984) Radiotherapy for jugulo-tympanic paragangliomas (glomus jugulare tumors). J Laryngol Otol 98:621 ff
Springate SC, Weichselbaum RR (1990) Radiation or surgery for chemodectomas of the temporal bone: A review of local control and complications. Head Neck 12:303 ff
Wang ML, Hussey DH, Doorbos JF et al. (1988) Chemodectoma of temporal bone: a comparison of surgical and radiotherapeutic results. Int J Radiat Oncol Biol Phys 14:643 ff
Zabel A, Milker-Zabel S, Schulz-Erner D et al. (2003) Fraktionierte stereotaktische Konformationsbestrahlung von Glomus jugulare Tumoren. Strahlenther Onkol 179:67 ff
Zu Juveniles Nasen-Rachen-Fibrom
Antonelli AR, Cappiello J, Donajo CA et al. (1997) Diagnosis, staging and treatment of juvenile nasopharyngeal angiofibroma. Laryngoscope 97:1319–1325
Chandler JR, Goulding R, Moskowitz L et al. (1984) Nasopharyngeal angiofibromas: Staging and management. Ann Otol Rhinol Laryngol 93:322–329
Cummings BJ, Blend R, Keane T (1984) Primary radiation therapy for juvenile nasopharyngeal angiofibroma. Laryngoscope 94:1599–1605
Economou TS, Abemayor E, Ward PH (1988) Juvenile nasopharyngeal angiofibroma: an update of the UCLA experience, 1960–1985. Laryngoscope 98:170–175
Fields JN, Halverson KJ, Devineni VR et al. (1990) Juvenile nasopharyngeal angiofibroma: efficacy of radiation therapy. Radiology 176:263–265
Jereb J, Anggard A, Baryd I (1979) Juvenile nasopharyngeal angiofibroma. A clinical study of 69 cases. Acta Radiol Ther Phys Biol 9:302–310
Kuppersmith RB, Teh BS, Donovan DT et al. (2000) The use of intensity modulated radiotherapy for the treatment of extensive and recurrent juvenile angiofibroma. Int J Pediatr Otorhinolaryngol 52:261–268
Lee JT, Chen P, Safa A et al. (2002) The role of radiation in the treatment of advanced juvenile angio-fibroma. Laryngoscope 112 (7 Pt 1):1213–1220
Makek MS, Andrews JC, Fisch U (1989) Malignant transformation of a nasopharyngeal angiofibroma. Laryngoscope 99:1088–1092
McGahan RA, Durrance FY, Parke RB Jr et al. (1989) The treatment of advanced juvenile nasopharyngeal angiofibroma. Int J Radiat Oncol Biol Phys 17:1067–1072
Million RR, Cassisi NJ, Mancuso AA, Stringer SP (1994) Juvenile Angiofibroma. In: Million RR, Cassisi NJ (eds) Management of head and neck cancer. A multidisciplinary approach. 2nd edn. Philadelphia, pp 627–641
Reddy KA, Mendenhall WM, Amdur RJ et al. (2001) Long-term results of radiation therapy for juvenile nasopharyngeal angiofibroma. Am J Otolaryngol 22:172–175
Robinson ACR, Khouri GG, Ash DV et al. (1989) Evaluation of response following irradiation of juvenile angiofibromas. Br J Radiol 62:245–247
Sinha PP, Aziz HI (1978) Juvenile nasopharyngeal angiofibroma. A report of seven cases. Radiology 127(2):501–503
Spector JG (1998) Management of juvenile angiofibromata. Laryngoscope 98:1016–1026
Waldman SR, Levine HL, Astor F et al. (1981) Surgical experience with nasopharyngeal angiofibroma. Arch Otolaryngol 107:677–682
Zu Pterygium
Alaniz-Camino F (1982) The use of postoperative beta radiation in the treatment of pterygia. Ophthalmic Surg 3:1022–1025
Amano S, Motoyama Y, Oshika T, Eguchi S, Eguchi K (2000) Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery. Br J Ophthalmol 84:618–621
Beyer DC (1991) Pterygia: single-fraction post-operative beta irradiation. Radiology 178:569–571
Chen PO, Ariyasu RG, Kaza V, Labreé L, McDonnell PJ (1995) A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthal 12:151–160
De Keizer RJW (1982) Pterygium excision with or without post-operative irradiation. Documenta Ophthalmologica 52:309–315
De Keizer RJ (1997) Pterygium excision with free conjunctival autograft (FCG) versus post-operative strontium 90 (90Sr) beta-irradiation. A prospective study. Int Ophthalmol 21:335–341
Fukushima S, Onoue T, Onoue T, Ozeki S (1999) Post-operative irradiation of pterygium with 90Sr eye applicator. Int J Radiation Oncol Biol Phys 43:597–600
Jürgenliemk-Schulz IM, Hartman LJC, Roesink JM et al. (2004) Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial. Int J Radiat Oncol Biol Phys 59: 1138–1147
MacKenzie FS, Hirst LW, Kynaston B, Bain C (1991) Recurrence rate and complications after beta irradiation for ptergyia. Ophthalmology 98:1776–1780
Mahar PS, Nwokora GE (1993) Role of mitomycin C in pterygium surgery. Br J Ophthalmol 77:433–435
Monteiro-Grillo I, Gaspar L, Monteiro-Grillo M, Pires F, Ribeiro da Silva JM (2000) Post-operative irradiation of primary or recurrent pterygium: results and sequalae. Int J Radiation Oncol Biol Phys 48:865–869
Nishimura Y, Nakai A, Yoshimasu T et al. (2000) Long-term results of fractionated strontium-90 therapy for pterygia. Int J Radiat Oncol Biol Phys 46:137–141
Rubinfield RS, Pfister RR, Stein RM et al. (1992) Serious complication of topical mitomycin C after pterygium surgery. Ophthalmology 99:1647–1654
Paijc B, Pugnale-Verilotte N, Greiner RH, Paijc D, Eggspuhler A (2002) Results of strontium-yttrium-90 for pterygia. J Fr Ophthalmol 25:473–479
Pajic B, Pallas A, Aebersold D, Gruber G, Greiner RH (2004) Prospective study on exclusive, nonsurgical strontium-/yttrium-90 irradiation of pterygia. Strahlenther Onkol 180:510–516
Parayani SB, Scott WP, Wells JW Jr et al. (1994) Management of pterygium with surgery and radiation therapy. The North Florida Pterygium Study Group. Int J Radiat Oncol Biol Phys 28:101–103
Schultze J, Hinrichs M, Kimmig B (1996) The results of strontium-90 contact therapy to prevent the recurrence of pterygium. Germ J Ophthalmol 5:207–210
Smith RA, Dzugan SA, Kosko P (2001) Postoperative beta irradiation for control pterygium. J Miss State Med Assoc 42:167–169
Wesberry JM, Wesberry JM Sr (1993) Optimal use of beta irradiation in the treatment of pterygia. South Med J 86:633–637
Wilder RB, Buatti JM, Kittelson JM et al. (1992) Pterygium treated with excision and post-operative beta-irradiation. Int J Radiation Oncol Biol Phys 23:533–537
Willner J, Flentje M, Lieb W et al. (2001) Soft X-ray therapy of recurrent pterygium-an alternative to Sr-90 eye applicators. Strahlenther Oncol 177:404–409
Zu Hämangiom der Aderhaut
Augsburger JJ, Freire J, Brady LW (1997) Radiation therapy for choroidal and retinal hemangiomas. In: Wiegel T, Bornfeld N, Foerster MH, Hinkelbein W (eds) Radiotherapy of ocular disease. Front Radiat Ther Oncol 30:pp 265–280
Frau E, Rumen F, Noel G et al. (2004) Low-dose proton beam therapy for circumscribed choroidal hemangiomas. Arch Ophthalmol 122:1471–1475
Hannouche D, Frau E, Desjardins L et al. (1997) Efficacy of proton therapy in circumscribed choroidal hemangiomas associated with serous retinal detachment. Opthalmology 104:1780–1784
Kivela T, Tenhunen M, Joensuu T et al. (2003) Stereotactic radiotherapy of symptomatic circumscribed choroidal hemangiomas. Opthalmology 110:1977–1982
Kreusel KM, Bornfeld N, Lommatzsch A et al. (1998) Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology 105(8):1386–1392
Madreperla SA, Hungerford JL, Plowman PN et al. (1997) Choroidal hemangiomas – visual and anatomic results of treatment by photocoagulation or radiation therapy. Ophthalmology 104:1773–1779
Madreperla SA (2001) Choroidal hemangioma treated with photodynamic therapy using verteporfin. Arch Ophthalmology 119:1606–1610
Mashayekhi A, Shields CL (2003) Circumscribed choroidal hemangioma. Curr Opin Ophthalmol 14:142–149
Plowman PN, Hungerford JL (1997) Radiotherapy for ocular angiomas. Br J Ophthalmol 81:258–259
Sanborn GE, Augsburger JJ, Shields JA (1982) Treatment of circumscribed choroidal hemangiomas. Opthalmology 89:1374–1380
Schilling H, Sauerwein W, Lommatzsch A et al. (1997) Long-term results after low dose ocular irradiation for choroidal hemangiomas. Br J Ophthalmol 81:267–273
Shields CL, Shields JA, Barrett J et al. (1995) Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol 113:615–623
Shields CL, Honavar SC, Shields JA et al. (2001) Circumscribed choroidal hemangioma. Clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 108:2237–2248
Shields JA, Shields CL, Materin MA et al. (2004) Changing concepts in management of circumscribed choroidal hemangioma. The 2003 J Howard Stokes Lecture (Part 1). Ophtalmic Surg Lasers 35:383–393
Witschel H, Font RL (1976) Hemangioma of the choroid: A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol 20:415–431
Zografos L, Gailloud C, Bercher L (1989) Irradiation treatment of choroidal hemangiomas. Fr Ophthalmol 12:797–807
Zografos L, Bercher L, Chamot L et al. (1996) Cobalt-60 treatment of choroidal hemangiomas. Am J Opthalmol 121:190–199
Zografos L, Egger E, Bercher L et al. (1998) Proton beam irradiation of choroidal hemangiomas. Am J Ophthalmol 126:261–268
Zu Altersbedingte Makuladegeneration
Bergink GJ, Deutman AF, Van den Broek JFCM et al. (1994) Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 232:591–598
Bergink GJ, Hoyng CB, Van der Maazen RWM et al. (1998) A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in ages-related macular degeneration: Radiation versus observation. Graefes Arch Clin Exp Ophthalmol 236:321–325
Berta A, Vezendi L, Vamosi P (1995) Irradiation of macular subretinal neovascularisation using ruthenium applicators. Szemeset (Hung J Ophthalmol) 13:67–75
Chakravarty M, Gardiner TA, Archer DB et al. (1993) Treatment of age-related subfoveal choroidal neovascular membranes by teletherapy: A pilot study. Br J Ophthalmol 77:265–273
Char DH, Irvine AI, Posner MD et al. (1999) Randomized trial of radiation for age-related macular degeneration. Am J Ophthalmol 127:574–578
Fine SL, Maguire MG (2001) It is not time to abandon radiotherapy for neovascular age-related macular degeneration. Arch Ophthalmol 119:275–276
Finger PT, Berson A, Ng T, Szchecter A (1999) Ophthalmic plaque radiation therapy for age-related macular degeneration associated with subretinal neovascularisation. Am J Ophthalmol 127:170–177
Finger PT, Berson A, Sherr DA, Riley R, Balkin RA, Bosworth JL (1996) Radiation therapy for subretinal neovascularisation. Ophthalmology 103:878–889
Finger PT, Immonen I, Freire J, Brown G (2001) Brachytherapy for macular degeneration associated with subretinal neovascularisation. In: Alberti WE, Richard G, Sagerman RH (eds) Age-related macular degeneration. Current treatment concepts. Springer, Berlin Heidelberg New York Tokio, pp 167–173
Hart PM, Chakravarthy U, MacKenzie G et al. (1996) Teletherapy for subfoveal choroidal neovascular-isation of age related macular degeneration: Results of follow up in a non-randomised study. Br J Ophthalmol 80:1046–1050
Hart PM, Chakravarthy U, Mackenzie G et al. (2002) Visual outcomes in the subfoveal radiotherapy study. Arch Ophthalmol 120:1029–1039
Hoeller U, Fuisting B, Schwartz R, Roeper B, Richard G, Alberti W (2005) Results of radiotherapy of subfoveal neovascularization with 16 and 20 Gy. Eye 19(11):1151–1156
Hollick EJ, Goble RR, Knowles PJ et al. (1996) Radiotherapy treatment of age-related subfoveal neovascular membranes in patients with good vision. Eye 10:609–616
International ARM Epidemiological Study Group (1995) An international classification system for ARM. Surv Ophthalmol 39:367–374
Jaacola A, Heikkonen J, Tomilla et al. (1998 a) Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 236:24–30
Jaakola A, Heikkonen J, Tarkkanen A, Immonen I (1998 b) Visual function after Strontium-90 plaque irradiation in patients with age-related subfoveal choroidal neovascularisation. Acta Ophthalmol Scand 76:1–5
Kobayashi H, Kobayashi K (2000) Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes. Am J Ophtalmol 130:617–635
Marcus DM, Sheils WC, Johnson MH et al. (2001) External beam irradiation of subfoveal choroidal neovascularisation complicating age-related macular degeneration: one-year-results of a prospective, double-masked, randomised clinical trial. Arch Ophthalmol 119:171–180
Mauget-Faysse M, Chiquet C, Milea D et al. (1999) Long term results of radiotherapy for subfoveal choroidal neovascularistion in age related macular degeneration. Br J Ophthalmol 83:923–928
Miller JW, Walsh AW, Kramer M et al. (1995) Photodynamic therapy of experimental choroidal neo-vascularisation using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 113:810–818
Munzenrider JE, Castro JR (1993) Particle treatment of the eye. In: Alberti WE, Sagerman RH (eds) Radiotherapy of intraocular and orbital tumors. Springer, Berlin Heidelberg New York Tokio, pp 45–55
Pauleikhoff D, Holz FG (1996) Die altersabhängige Makuladegeneration. Ophthalmologe 93:299–315
Pöstgens H, Bodanowitz S, Kroll P (1997) Low dose radiation therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 235:656–661
Prettenhofer M, Haas A, Mayer R, Oechs A et al. (1998) The photon therapy of subfoveal choroidal neovascularisation in age-dependant macular degeneration – the result of a prospective study in 40 patients. Strahlenther Onkol 174:613–617
RAD (The Radiation Therapy for Age-related Macular Degeneration Study) (1999) A prospectiv, randomized, double-masked trial on radiation therapy for neovascular age-related degeneration. Ophthalmol 106:2239–2247
Sasai K, Murara R, Mandai M et al. (1997) Radiation therapy for ocular choroidal neovascularization (phase I/II study): Preliminary report. Int J Radiat Oncol Biol Phys 39:173–178
Spaide RF, Guyer DR, McCormick B et al. (1998) External beam radiation therapy for choroidal neo-vascularisation. Ophthalmology 105:24–30
Staar S, Krott R, Mueller R-P et al. (1999) External beam radiotherapy for subretinal neovascularisation in age-related macular degeneration. Is this treatment efficient? Int J Radiat Oncol Biol Phys 45:467–473
Stalmans P, Leys A, Van Limbergen E (1997) External beam radiotherapy (20 Gy, 2 fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: A review of 111 cases. Retina 17:481–492
Thölen A, Meister A, Bernasconi PP et al. (1998) Radiotherapie von subretinalen Neovaskularisations-membranen bei altersabhängiger Makuladegeneration. Ophthalmologe 95:691–698
Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. One-year results of two randomised clinical trials-TAP report. I Arch Ophthalmol 117:1329–1345
Valmaggia C, Ries G, Ballinari P (2002) Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: A randomized clinical trial. Am J Ophthalmology 133:521–529
Yonemoto LT, Slater JD, Blacharski PB et al. (2000) Dose response in the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: Results of a phase I/II dose escalation study using proton radiotherapy. J Radiosurg 3:47–54
Zu Endokrine Orbitopathie
Bahn RS, Dutton CM, Naff N et al. (1998) Thyrotropin receptor expression in Graves’ orbital adipose/connective tissues: potential autoantigen in Graves’ ophthalmopathy. J Clin Endocrinol Metab 83:998–1002
Bartalena L, Marcocci C, Chiovato L et al. (1983) Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 56:1139–1144
Broerse JJ, Snijders-Keilholz A, Jansen JTM et al. (1999) Assessment of carcinogenic risk for treatment of Graves’ ophthalmopathy in dependence on age and irradiation geometry. Radiother Oncol 53:205–208
Burch HB, Wartofsky L (1993) Graves’ ophthalmopathy. Current concepts regarding pathogenesis and management. Endocr Rev 146:747 ff
Donaldson SS, Bagshaw MA, Kriss JP et al. (1973) Supervoltage orbital radiotherapy for Graves’ ophthalmo-pathy. J Clin Endocrinol Metab 37:276–285
Donaldson SS, McDougall IR, Kriss JP (1993) Graves’ Disease. In: Alberti WE, Sagerman RH (eds) Radiotherapy of intraocular and orbital tumors. Springer, Berlin Heidelberg New York Tokio, pp 191–197
Donaldson SS, McDougall IR (2002) Graves’ Disease. Radiotherapy of intraocular and orbital tumors. In: Alberti WE, Sagerman RH (eds) Radiotherapy of intraocular and orbital tumors. 2nd edn. Springer, Berlin Heidelberg New York Tokio, pp 145–152
Esser J, Sauerwein W, Olbricht T et al. (1995) Corticoid- und Strahlentherapie bei endokriner Orbitopathie. Nuklearmediziner 18:163–177
Friedrich A, Kamprad F, Goldmann A et al. (1997) Clinical importance of radiotherapy in the treatment of Graves’ Disease. In: Wiegel T, Bornfeld N, Foerster MH, Hinkelbein W (eds) Radiotherapy of ocular disease. Front Radiat Ther Oncol (Basel) 30:206–217
Gerling J, Kommerell G, Henne K et al. (2003) Retrobulbar irradiation for thyroid-associated orbitopathy: double blind comparison between 2.4 and 16 Gy. Int J Radiat Oncol Biol Phys 55:182–189
Heyd R, Seegenschmiedt MH, Strassmann G et al. (2003) Radiotherapy of Graves’ Orbitopathy: results of a national survey. Strahlenther Onkol 179:372–376
Hurbli T, Char DH, Harris J et al. (1985) Radiation therapy for thyroid eye diseases. Am J Ophthalmol 99:633–637
Jansen JTM, Broerse J, Zoetelief J, Klein C, Seegenschmiedt MH (2001) Assessment of carcinogenic risk in the treatment of benign disease of knee and shoulder joint. In: Seegenschmiedt MH, Makoski HB (Hrsg) 15. Kolloquium Radioonkologie/Strahlentherapie, Radiotherapie bei gutartigen Erkrankungen. Diplodocus-Verlag, Altenberge, pp 13–15
Jansen JT, Broerse JJ, Zoetelief J, Klein C, Seegenschmiedt HM (2005) Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel. Radiother Oncol 76(3):270–277
Kahaly G, Förster G, Pitz S, Rösler HP, Mann W (1997) Aktuelle interdisziplinäre Diagnostik und Therapie der endokrinen Orbitopathie. Dtsch med Wschr 122:27–32
Kinyoun JL, Orcutt JC (1987) Radiation retinopathy. J Am Med Ass 258:610–611
Lloyd WC, Leone CR (1992) Supervoltage orbital radiotherapy in 36 cases of Graves’ disease. Am J Ophthalmol 113:374–380
Marcocci C, Bartalena L, Panicucci M et al. (1987) Orbital cobalt irradiation combined with retrobulbar or systematic corticosteroids for Graves’ ophthalmopathy: a comparative study. Clin Endocrinol 27:33–42
Miller ML, Goldberg SH, Bullock JD (1991) Radiation retinopathy after radiotherapy for thyroid-related ophthalmopathy. Am J Ophthalmol 112:600–601
Mourits M, Koornneef L, Wiersinga WM et al. (1990) Orbital decompression for Graves’ ophthalmopathy by inferomedial plus lateral and by coronal approach. Ophthalmology 97:636–641
Nygaard B, Specht L (1998) Transitory blindness after retrobulbar irradiation of Graves’ ophthalmopathy. Lancet 351:725–726
Marten et al. (1999) RTO 53 (Suppl 1) Abstr. 17
Olivotto IA, Ludgate CM, Allen LH et al. (1985) Supervoltage radiotherapy for Graveś ophthalmopathy: CCABC technique and results. Int J Radiat Oncol Biol Phys 11:2085–2090
Order SE, Donaldson SS (1990) Radiation therapy of benign diseases. A clinical guide. Springer, Berlin Heidelberg New York Tokio
Palmer D, Greenberg P, Cornell P, Parker RG (1987) Radiation therapy for Graves’ ophthalmopathy. A retrospective analysis. Int J Radiat Oncol Biol Phys 13:1815–1820
Petersen IA, Donaldson SS, McDougall IR, Kriss JP (1990) Prognostic factors in the radiotherapy of Graves’ ophthalmopathy. Int J Radiat Oncol Biol Phys 19:259–264
Prummel MF, Mourits MP, Blank L et al. (1993) Randomized double-blind trial of prednisone versus radiotherapy. In: Graves’ ophthalmopathy. Lancet 342:949–954
Prummel MF, Bakker A, Wiersinga WM et al. (2003) Multi-center study on the characteristics and treatment strategies of patients with Graves’ orbitopathy: first European Group on Graves’ orbitopathy experience. Eur J Endocrinol 148:491–495
Sandler HM, Rubenstein JH, Fowble BL et al. (1989) Results of radiotherapy for thyroid ophthalmopathy. Int J Radiat Oncol Biol Phys 17:823–827
Seegenschmiedt MH, Keilholz L, Gusek-Schneider G et al. (1998) Endokrine Orbitopathie: Vergleich der Langzeitergebnisse und Klassifikationen nach Radiotherapie. Strahlenther Onkol 174:449–456
Snijders-Keilholz A, De Keizer RJW, Goslings BM et al. (1996) Probable risk of tumor induction after retroorbital irradiation for Graves ophthalmopathy. Radiother Oncol 38:69–71
Staar S, Müller RP, Hammer M, Nolte M (1997) Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves’ Disease). In: Wiegel T, Bornfeld N, Foerster MH, Hinkelbein W (eds) Radiotherapy of ocular disease. Front Radiat Ther Oncol (Basel) 30:206–217
Van Leeuwen FE, Klokman WJ, Hagenbeek A et al. (1994) Second cancer risk following Hodgkin’s Disease: a 20-year follow-up. J Clin Oncol 12:312–325
Van Ouwerkerk BM, Wijngaarde R, Hennemann G et al. (1985) Radiotherapy of severe ophthalmic Graves’ disease. J Endocrinol Invest 8:241–247
Werner SC (1977) Modification of the classification of the eye changes of Graves’ disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association. J Clin Endocrinol Metab 44:203–204
Wilson WB, Prochoda M (1995) Radiotherapy for thyroid orbitopathy. Effects on extraocular muscle balance. Arch Ophthalmol 113:1420–1425
Zu Reaktive lymphoide Hyperplasie bzw. Pseudotumor orbitae
Ampil FL, Bahrassa FS (1985) Primary orbital lymphoma pseudotumor, case reports and review of radiotherapy literature. J Surg Oncol 30:91–95
Austin-Seymour MM, Donaldson SS, Egbert PR, McDougall IR, Kriss JP (1985) Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys 11:371–379
Barthold HJ, Harvey A, Markoe AM et al. (1986) Treatment of orbital pseudotumors and lymphoma. Am J Clin Oncol 9:527–532
Bogart JA, Sagerman RH, Chung CT (2002) Management of orbital lymphoma. In: Alberti WE, Sagerman RH (eds) Radiotherapy of intraocular and orbital tumors. 2nd edn. Springer, Berlin Heidelberg New York Tokio, pp 153–162
Donaldson SS, McDougall IR, Kriss JP (1993) Graves’ Disease. In: Alberti WE, Sagerman RH (eds) Radiotherapy of intraocular and orbital tumors. Springer, Berlin Heidelberg New York Tokio, pp 191–197
Donaldson SS, McDougall IR (2002) Graves’ Disease. Radiotherapy of intraocular and orbital tumors. In: Alberti WE, Sagerman RH (eds) Radiotherapy of intraocular and orbital tumors. 2nd edn. Springer, Berlin Heidelberg New York Tokio, pp 145–152
Fritzpatrick PI, Macko SL (1984) Lymphoreticular tumors of orbit. Int J Radiat Oncol Biol Phys 10:333–340
Flanders AE, Mafee MF, Rao VM, Choi KH (1989) CT characteristics of orbital pseudotumors and other inflammatory orbital processes. J Comput Assist Tomgr 13:40–47
Fujii H, Fujisada H, Kondo T, Takahashi T, Okada S (1985) Orbital pseudotumor: histopathological classification and treatment. Ophthalmol 190:230–242
Hogan M (1964) Discussion of orbital tumors. In: Boniuk M (ed) Ocular and adnexal tumors: new and controversial aspect. Mosby, St Louis, pp 447–458
Henderson JW (ed) (1980) Orbital tumors, 2nd ed: Lymphocytic inflammatory pseudotumor. Brian C.Decker, New York 1973:512–526
Isaacson PG, Norton AJ (eds) (1994) Extranodal lymphomas: Chapter 7: Lymphomas of the ocular adnexa and eye. Churchill Livingstone, Edinburgh, pp 117–129
Jacobiec FM, Jones JS (1979) Orbital inflammations. In: Duane (ed) Clinical ophthalmology XII. Mosby, Philadelphia
Jacobiec FA, McClean I, Font FL (1979) Clinicopathologic characteristics of orbital lymphoid hyperplasia. Ophtalmology 86:948–952
Keleti D, Flickinger JC, Hobson SR, Mittal BB (1992) Radiotherapy of lymphoproliferative diseases of the orbit: surveillance of 65 cases. Am J Clin Oncol 15:422–427
Kennerdell JS, Johnson BL, Deutsch M (1979) Radiation treatment of orbital lymphoid hyperplasia. Ophthalmology 86:942–947
Knowles DM, Jacobiec FA (1989) Orbital lymphoid neoplasms: A clinical pathologic study of 60 patients. Cancer 46:576–589
Lambo MJ, Brady LW, Shields CL (1993) Lymphoid tumors of the orbit. In: Alberti WE, Sagerman RH (eds) Radiotherapy of intraocular and orbital tumors. Springer, Berlin Heidelberg New York Tokio, pp 205–216
Lanciano R, Fowble B, Sergott R et al. (1989) The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys 18:407–411
Leone C, Lloyd T (1985) Treatment protocol for orbital inflammatory disease. Ophthalmology 92:1325–1331
Mittal BB, Deutsch M, Kennerdell J, Johnson B (1986) Paraocular lymphoid tumors. Radiology 159:793–796
Notter M, Kern T, Forrer A, Meister F, Schwegler N (1997) Radiotherapy of pseudotumor orbitae. Front Radiat Ther Oncol 30:180–191
Notter M (2000) Strahlentherapie bei pseudotumor orbitae. In: Seegenschmiedt MH, Makoski HB (eds) Radiotherapie gutartiger Erkrankungen, Symposium 5.–6. März 2000. Diplodocus, Altenberge, S 123–136
Orcutt JC, Garner A, Henk JM, Wright JE (1983) Treatment of idiopathic inflammatory orbital pseudotumot by radiotherapy. Br J Ophthalmol 67:570–574
Rao DV, Cosby K, Smith M, Griffith R (1982) Lymphomas and pseudolymphomas of the orbit (abstr.). Int J Radiat Oncol Biol Phys 8 (Suppl):114
Sergott RC; Gaser JS; Charyulu K (1981) Radiotherapy of idiopathic inflammatory pseudotumor: Indications and results. Arch Ophthalmol 99:853–856
Sigelman J, Jacobiec F (1978) Lymphoid lesions of the conjunctiva: Relation of histopathology and outcome. Ophthalmology 85:818–843
Snijders-Keilholz A, De Keinzer RJW, Goslings BM et al. (1996) Probable risk of tumor induction after retro-orbital irradiation for Grave’s ophthalmopathy. Radiother Oncol 38:69–71
Wagner W, Gerding H, Busse H (1992) Pseudotumor orbitae – ein Chamäleon in Diagnostik und Therapie? Strahlenther Onkol 168:528–535
Waldman TA, Korsmeyer SJ, Bakshi A et al. (1985) Molecular genetic analysis of human lymphoid neoplasms. Immunoglobulin genes and the c-myc oncogene. Ann Int Med 102:497–510
Yamashita K, Kobayashi S, Kando M et al. (1995) Elevated anti neutrophil cytoplasmatic antibody titer in a patient with atypical orbital pseudotumor. Ophthalmologica 209:172–175
Zu Allgemeine Gesichtspunkte
Constant CR, Murley AHG (1987) A clinical method of functional assessment of the shoulder. Clin Orthop Rel Res 214:160–164
Gocht H (1897) Therapeutische Verwendung der Röntgenstrahlen. Fortschr Röntgenstr 1:14
Insall J (1989) Rationale of the knee society clinical rating system. Clinical Orthop 248:13–14
Keilholz L, Seegenschmiedt MH, Sauer R (1998) Radiotherapy of degenerative joint disorders. Indication, technique and clinical results. Strahlenther Onkol 174:243–250
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502
Goldie I, Rosengren B, Moberg E et al. (1970) Evaluation of radiation treatment of painful conditions of the locomotor system. Acta Radiol Ther Phys 9:311–322
Harris WH (1976) Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by Mold arthroplasty. End result study using new method of evaluation. J Bone Joint Surg 51A:737–755
Leer JWH, van Houtte P, Daelaar J (1998) Indications and treatment schedules for irradiation of benign diseases: a survey. Radiother Oncol 48:249–257
Micke O, Seegenschmiedt MH (2002) The German Working Group guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 52:496–513
Morrey BF, An KN, Chao EY (1985) Functional evaluation of the elbow. In: Morrey BF (ed) The elbow and its disorders. Saunders Co., Philadelphia London Toronto, pp 73–91
Order S, Donaldson SS (1999) Radiation Therapy of Benign Diseases, Medical Radiology, 2nd edn. Springer, Berlin Heidelberg New York Tokio
Plenk HP (1952) Calcifying tendinitis of the shoulder. A critical study of the value of X-ray therapy. Radiology 59:384–389
Rödel F, Kamprad F, Sauer R, Hildebrandt G (2002) Funktionelle und molekulare Aspekte der anti-inflamma-torischen Wirkung niedrig dosierter Radiotherapie: Strahlenther Onkol 178:1–9
Sasaki T, Monji Y, Tsuge Y (1987) High tibial osteotomy combined with anterior displacement of the tibial tubercle for osteoarthritis of knee. Internat J Orthopaedics 10:31–40
Seegenschmiedt MH, Keilholz L, Stecken A, Katalinic A, Sauer R (1996) Radiotherapie bei plantarem Fersensporn. Strahlenther Onkol 172:376–383
Seegenschmiedt MH, Keilholz L (1998) Epicondylopathia humeri and peritendinitis humero-scapularis: evaluation of radiation therapy long-term results and literature review. Radiother Oncol 47:17–28
Seegenschmiedt MH, Katalinic A, Makoski H et al. (2000) Radiation therapy for benign diseases: patterns of care study in Germany. Int J Radiat Oncol Biol Phys 47:195–202
Tegner Y, Lysholm D (1985) Rating systems in evaluation of knee ligament injuries. Clin Orthop 198:43–49
Valtonen EJ, Lilius HG, Malmio K (1975) The value of roentgen irradiation in the treatment of painful degenerative and inflammatory musculo-skeletal conditions. Scand J Rheumatol 4:247–249
von Pannewitz G (1933) Die Röntgentherapie der Arthritis deformans. Klinische und experimentelle Untersuchungen. Ergebn Med Strahlenforsch 6:62–126
von Pannewitz G (1970) Degenerative Erkrankungen. In: Diethelm L, et al. (eds) Handbuch der medizinischen Radiologie Band XVII. Springer, Berlin Heidelberg New York Tokio, S 73–107
Zu Bursitis
Schunck J, Jerosch J (2004) Endoskopische Resektion der Bursa trochanterica. Arthroskopie: 96–99
Leitzen C, Seegenschmiedt MH (2005) Radiotherapie bei Bursitis trochanterica. In: Seegenschmiedt MH, Micke O (eds) Radiotherapie bei gutartigen Erkrankungen, Symposium 11.–12. März 2005, Diplodocus, Altenberge, S 87–96
Zu Peritendinopathia humeroscapularis
Adamietz B, Sauer R (2003) Strahlentherapie beim Impingement-Syndrom des Schultergelenks. Strahlenther Onkol 179(Sondernr 1):1
Baensch WE (1953) Röntgentherapie der Tendinitis calcarea. Strahlentherapie 90:514–518
Goldie I, Rosengren B, Moberg E et al. (1970) Evaluation of radiation treatment of painful conditions of the locomotor system. Acta Radiol Ther Phys 9:311–322
Hassenstein E, Nüsslin F, Hartweg H, Renner KH (1979) Die Strahlenbehandlung der Periarthritis humeroscapularis. Strahlentherapie 155:87–93
Hassenstein EOM (1986) Die Strahlenbehandlung gutartiger Erkrankungen – Indikationen, Ergebnisse und Technik. Röntgen-Blätter 39:21–23
Hess F, Bonmann KH (1955) Die Röntgentherapie der Arthrosen, Spondylosen, der Periarthritis humeroscapularis und der Epicondylitis. Strahlentherapie 96:75–81
Hess F (1980) Die Entzündungsbestrahlung. Dtsch Ärztebl 17:1119–1121
Jenkinson EL, Norman RC, Wilson IA (1952) Radiation therapy of the nontraumatic painful shoulder. Radiology 58:192–197
Keilholz L, Seegenschmiedt MH, Kutzki D, Sauer R (1995) Radiotherapy of the periarthritis humeroscapularis. Strahlenther Onkol 171:379–384
Keinert K, Schumann E, Grasshof S (1972) Die Strahlentherapie der Periarthritis humero-scapularis. Radiobiol Radiother 13:3–8
Kutzner J, Störkel S, Schilling F, Zapf S (1988) Die Bestrahlung als Therapie bei der sternokostoklaviculären Hyperostose. Med Klin 83:516–519
Lindner H, Freislederer R (1982) Langzeitergebnisse der Bestrahlung von degenerativen Gelenkerkrankungen. Strahlentherapie 158:217–223
Mustakallio S (1939) Über die Röntgenbehandlung der Periarthritis humeroscapularis. Acta Radiol (Stockh) 20:22–32
Plenk HP (1952) Calcifying tendinitis of the shoulder. A critical study of the value of X-ray therapy. Radiology 59:384–389
Reinhold H, Sauerbrey R (1961) Die Röntgentherapie des Schulter-Arm-Syndroms, Epikondylitiden an Schulter und Ellenbogen. Dtsch Med Wschr 86:163–168
Sautter-Bihl ML, Liebermeister E, Scheurig H et al. (1993) Analgetische Bestrahlung degenerativ-entzündlicher Skeletterkrankungen. Dtsch Med Wschr 118:493–498
Seegenschmiedt H, Keilholz L (1998) Epicondylopathia humeri and peritendinitis humeroscapularis: evaluation of radiation therapy long-term results and literature review. Radiother Oncol 47:17–28
Wieland C, Kuttig H (1965) Hochvolttherapie bei Arthrosen und Entzündungen. Strahlentherapie 127:44–48
Zschache H (1972) Ergebnisse der Röntgenschwachbestrahlung. Radiobiol Radiother 13:181–186
Zwicker C, Hering M, Brecht L, Kuhne-Velte HJ, Kern A (1998) Strahlentherapie der Periarthritis humeroscapularis mit ultraharten Photonen. Vergleich mit kernspintomographischen Befunden. Radiologe 38:774–778
Zu Epicondylopathia humeri
Cocchi U (1943) Erfolge und Mi?erfolge bei Röntgenbestrahlung nichtkrebsiger Leiden. Strahlentherapie 73:255–284
Coonrad RW, Hooper WR (1973) Tennis elbow: Its course, natural history, conservative and surgical management. J Bone Joint Surg 55-A:1177–1780
Gärtner C, Schüttauf M, Below M et al. (1988) Zur strahlentherapeutischen Behandlung chronisch-rezidivierender Skelettveränderungen an der Klinik für Onkologie. Radiobiol Radiother 29:687–696
Hess F (1980) Die Entzündungsbestrahlung. Dtsch Ärztebl 17:1119–1121
Kammerer R, Bollmann G, Schwenger P et al. (1990) Ergebnisse der Strahlentherapie der Epicondylitis humeri bei unterschiedlicher Dosierung. Radiobiol Radiother 31:503–507
Keim H (1965) Mitteilung über die Durchführung der Entzündungsbestrahlung mit dem Telekobaltgerät. Strahlentherapie 127:49–52
Mantell BS (1986) The management of benign conditions. In: Hope-Stone HF (ed) Radiotherapy in clinical practice. Butterworths, London, pp 384–399
Sautter-Bihl M-L, Liebermeister E, Scheurig H et al. (1993) Analgetische Bestrahlung degenerativ – entzündlicher Skeletterkrankungen. Dtsch Med Wschr 118:493–498
Seegenschmiedt MH, Keilholz L, Martus P et al. (1997) Epicondylopathia humeri: Indication, technique and clinical results of radiotherapy. Strahlenther Onkol 173:208–218
Seegenschmiedt MH, Keilholz L (1998) Epicondylopathia humeri and peritendinitis humeroscapularis: evaluation of radiation therapy long-term results and literature review. Radiother Oncol 47:17–28
Siebert W, Seichert N, Siebert B et al. (1987) What is the efficacy of soft and mild lasers in therapy of tendinopathies? A double-blind study. Arch Orthop Trauma Surg 106:358–363
von Pannewitz G (1960) Zur Röntgentherapie entzündlicher Krankheiten. Med Welt 10:181–189
von Pannewitz G (1970) Degenerative Erkrankungen In: Handbuch der medizinischen Radiologie Bd. XVII. Springer, Berlin Heidelberg New York Tokio, S 96–98
Wieland C, Kuttig H (1965) Hochvolttherapie bei Arthrosen und Entzündungen. Strahlentherapie 127:44–48
Zschache H (1972) Ergebnisse der Röntgenschwachbestrahlung. Radiobiol Radiother 13:181–186
Zu Kalkaneodynie
Basche S, Drescher W, Mohr K (1980) Ergebnisse der Röntgenstrahlentherapie beim Fersensporn. Radiobiol Radiother 21:233–236
Cocchi U (1943) Erfolge und Mißerfolge bei Röntgenbestrahlung nichtkrebsiger Leiden. Strahlentherapie 73:255–284
Glatzel M, Bäsecke S, Krauß A et al. (2001) Radiotherapy of painful plantar heel spur. BenigNews 2(2):18–19
Heyd R, Strassmann G, Filipowicz I et al. (2001) Radiotherapy in the management of inflammatory calcaneal heel spurs: results of a prospektive study. In: Seegenschmiedt MH, Makoski HB (Hrsg) 11. Kolloquium Radioonkologie/Strahlentherapie. Radiotherapie von gutartigen Erkrankungen. Diplodocus Press, Altenberge, S 173–183
Keim H (1965) Mitteilung über die Durchführung der Entzündungsbestrahlung mit dem Telekobaltgerät. Strahlentherapie 127:49–52
Koeppen D, Bollmann G, Gademann G (2000) Ein Beitrag zur Dosiswirkungsbeziehung bei der Röntgentherapie des Fersensporns (Abstr.) Strahlenther Onkol 176 (Suppl 1):91
Mantell BS (1986) The management of benign conditions. In: Hope-Stone HF (ed) Radiotherapy in clinical practice. Butterworths, London, pp 384–399
Mitrov G, Harbov I (1967) Unsere Erfahrungen mit der Strahlentherapie von nichttumorartigen Erkrankungen. Radiobiol Radiother 8:419–423
Oehler W, Hentschel B (2000) Niedrigdosierte analgetische Radiotherapie von Arthrosen. Ärztebl Thüring 11:92–95
Sautter-Bihl M-L, Liebermeister E, Scheurig H et al. (1993) Analgetische Bestrahlung degenerativ-entzündlicher Skeletterkrankungen. Dtsch Med Wschr 118:493–498
Schäfer U, Micke O, Glashörster M et al. (1995) Strahlentherapeutische Behandlung des schmerzhaften Fersenbeinsporns. Strahlenther Onkol 171:202–206
Schreiber H, Böhnlein G, Ziegler K (2000) Strahlentherapie des schmerzhaften Fersensporns. In: Seegenschmiedt MH, Makoski HB (Hrsg) 10. Kolloquium Radioonkologie/Strahlentherapie. Radiotherapie von gutartigen Erkrankungen. Diplodocus Press, Altenberge, S 186
Seegenschmiedt MH, Keilholz L, Katalinic A et al. (1996) Heel spur: radiation therapy for refractory pain – results with three treatment concepts. Radiology 200:271–276
Seegenschmiedt MH, Keilholz L, Stecken A et al. (1996) Radiotherapy of plantar heel spur: indication, technique and clinical results for different dose concepts. Strahlenther Onkol 172:376–383
Wieland C, Kuttig H (1965) Hochvolttherapie bei Arthrosen und Entzündungen. Strahlentherapie 127:44–48
Zschache H (1972) Ergebnisse der Röntgenschwachbestrahlung. Radiobiol Radiother 13:181–186
Zu Osteoarthrosis deformans
Hess F (1980) Die Entzündungsbestrahlung. Dtsch Ärztebl 17:1119–1121
Hess F (1982) Die Strahlentherapie entzündlicher und degenerativer Erkrankungen. Therapiewoche 32:4798–4804
Hess F (1986) Die Strahlentherapie gutartiger Erkrankungen. Dtsch Ärztebl 83:3374–3376
Zu Desmoid (aggressive Fibromatose
Acker JC, Bossen EH, Halperin EC (1993) The management of desmoid tumors.Int J Radiat Oncol Biol Phys 26:851–858
Assad WA, Nori D, Hilaris BS et al. (1986) Role of brachytherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 12:901–906
Atahan I, Lale F, Akyol F et al. (1989) Radiotherapy in the management of aggressive fibromatosis. Brit J Radiol 62:854–856
Bataini JP, Belloir C, Mazabraud A et al. (1988) Desmoid tumors in adults: the role of radiotherapy in their management. Am J Surg 155:754–760
Ballo MT, Zagars GK, Pollack A (1999) Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy or combined surgery and radiation therapy. J Clin Oncol 17:158–167
Belliveau P, Graham AM (1984) Mesenteric desmoid tumor in Gardner’s syndrome treated by Sulindac. Dis Colon Rect 10:53–54
Bataini JP, Belloir C, Mazabraud A et al. (1988) Desmoid tumors in adults: The role of radiotherapy in their management. Am J Surg 155:754–760
Enzinger FM, Shiraki M (1967) Musculo-aponeurotoc fibromatosis of the shoulder girdle (extra-abdominal desmoid). Cancer 20:1131–1140
Greenberg HM, Goebel R, Weichselbaum RR et al. (1981) Radiation therapy in the treatment of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 7:305–310
Goy BW, Lee SP, Eilber F et al. (1997) The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 39:659–665
Hoffmann W, Weidmann B, Schmidberger H et al. (1993) Klinik und Therapie der aggressiven Fibromatose (Desmoide). Strahlenther Onkol 169:235–241
Kamath SS, Parsons JT, Marcus RB (1996) Radiotherapy for local control of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 36:325–328
Karakousis P, Mayordomo J, Zografos GO et al. (1993) Desmoid tumors of the trunk and extremity. Cancer 72:1637–1641
Keus RB, Bartelink H (1986) The role of radiotherapy in the treatment of desmoid tumors. Radiother Oncol 7:1–5
Kiel KD (1984) Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer 54:2051–2055
Kinzbrunner B, Ritter S, Domingo J (1983) Remission of rapidly growing desmoid tumors after tamoxifen. Cancer 52:2201–2204
Kirschner MJ, Sauer R (1993) Die Rolle der Radiotherapie bei der Behandlung von Desmoidtumoren. Strahlenther Onkol 169:77–82
Klein WA, Miller HH, Anderson M (1987) The use of indomethacin, sulindac and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer 60:2863–2868
Lanari A (1993) Effect of progesterone on desmoid tumors (aggressive fibromatoses). New Engl J Med 309:309–312
Leibel SA, Wara WM, Hill D et al. (1983) Desmoid tumors: Local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys 9:1167–1171
Leithner A, Schnack B, Katterschafka T et al. (2000) Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin. J Surg Oncol 73:21–25
McCullough WM, Parson JT, van der Griend R et al. (1991) Radiation therapy for aggressive fibro-matosis. J Bone Joint Surg 73A:717–725
Miralbell R, Suit HB, Mankin H et al. (1990) Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapy. Int J Radiat Oncol Biol Phys 18:535–540
Posner MC, Shiu MH, Newsome JL (1989) The desmoid tumor – not a benign disease. Arch Surg 124:191–196
Reitamo JJ, Scheinin TM, Häyvry (1986) The desmoid syndrome. Am J Surg 152:230–237
Sherman NE, Romsdahl M, Evans H et al. (1990) Desmoid tumors: a 20 year radiotherapy experience. Int J Radiat Oncol Biol Phys 19:37–40
Spear MA, Jennings LC, Mankin HJ (1998) Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40:637–645
Stockdale AD, Cassoni AM, Coe MA et al. (1998) Radiotherapy and conservative therapy in management of musculoaponeurotic fibromatosis. Int J Radiat Oncol Biol Phys 15:851–857
Suit HD (1990) Radiation dose and response of desmoid tumors. Int J Radiat Oncol Biol Phys 9:225–227
Suit HD, Spiro I (1999) Radiation treatment of benign mesenchymal disease. Sem Radiat Oncol 9:171–178
Walther E, Hünig R, Zalad S (1998) Behandlung der aggressiven Fibromatose. Orthopädie 17:193–200
Wadell WR, Gerner RE (1980) Indimethacin and ascorbate inhibit desmoid tumors. J Surg Oncol 15:85–90
Weiss AJ, Lackman RD (1989) Low-dose chemotherapy in desmoid tumors. Cancer 64:1192–1194
Wilcken N, Tattersall MH (1991) Endocrine therapy for desmoid tumors. Cancer 68:1384–1388
Zelefsky MJ, Harrison LB, Shiu MH et al. (1991) Combined surgical resection and iridium-192 implantation for locally advanced and recurrent desmoid tumors. Cancer 67:380–384
Zu Induratio penis plastica
Alth G, Koren H, Gasser G, Eidler R (1985) On the therapy of induratio penis plastica (Peyronie’s disease) by means of radium moulages. Strahlentherapie 161(1):30–34
Bruns F, Kardels B, Schäfer U, Schönekäs K, Willich N (1999) Strahlentherapie bei Induratio penis plastica. Röntgenpraxis 52:33–37
Feder BH (1971) Peyronie’s disease. J Am Geriatr Soc 19:947–951
Hauck EW, Weidner W (2001) Francois de la Peyronie and the disease named after him. Lancet 357:2049–2051
Helvie WW, Ochsner SF (1972) Radiation therapy in Peyronie’s disease. South Med J 65:1192–1196
Incrocci L, Wijnmaalen A, Slob AK et al. (2000) Low-dose radiotherapy in 179 patients with Peyronie’s disease: treatment outcome and current sexual function. Int J Radiat Oncol Biol Phys 47:1353–1356
Kelami A (1983) Classification of congenital and acquired penile deviation. Urol Int 38:229–232
Martin CL (1972) Long time study of patients with Peyronie’s disease treated with irradiation. AJR Am J Roentgenol 114:492–495
Micke O, Seegenschmiedt MH (2002) German Working Group guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 52:496–513
Mira JG, Chahbazian CM, del Regato JA (1989) The value of radiotherapy for Peyronie’s disease: Presentation of 56 new case studies and review of the literature. Int J Radiat Oncol Biol Phys 6:161–166
Nesbit RM (1950) Congenital curvature of the phallus. Report of three cases with description of corrective operation. J Urol 93:230–232
Pambor M, Schmidt W, Wiesner M, Jahr U (1985) Induratio penis plastica – Ergebnisse nach kombinierter Behandlung mit Röntgenbestrahlung und Tokopherol. Z Klin Med 40:1425–1427
Rodrigues CI, Hian Njo, Karim AB (1995) Results of radiotherapy and vitamin E in the treatment of Peyronie’s disease. Int J Radiat Oncol Biol Phys 31:571–574
Schubert GE (1991) Anatomy and pathophysiology of Peyronie’s disease and congenital deviation of the penis. Urol Int 47:231–235
Viljoen IM, Goedhals L, Doman MJ (1993) Peyronie’s disease: A perspective on the disease and the long-term results of radiotherapy. S Afr Med J 83:19–20
Williams JL, Thomas CG (1970) The natural history of Peyronie’s disease. J Urol 103:75–76
Wagenknecht LV, Meyer WH, Kiskemann A (1982) Wertigkeit verschiedener Therapieverfahren bei Induratio penis plastica. Urol Int 37:335–348
Weisser GW, Schmidt B, Hübener KH, Ahlemann LM, Kordonias D (1987) Die Strahlenbehandlung der Induratio penis plastica. Strahlenther Onkol 163:23–28
Zu Dupuytren-Erkrankung und Ledderhose-Syndrom
Adamietz B, Keilholz L, Grünert J, Sauer R (2001) Die Radiotherapie des Morbus Dupuytren im Frühstadium. Langzeitresultate nach einer medianen Nachbeobachtungszeit von 10 Jahren. Strahlenther Onkol 177:604–610
Finney R (1955) Dupuytren’s contracture. Brit J Radiol 28:610–613
Herbst M, Regler G (1985) Dupuytrensche Kontraktur. Radiotherapie der Frühstadien. Strahlentherapie 161:143–147
Hesselkamp J, Schulmeyer M, Wiskemann A (1981) Röntgentherapie der Dupuytrenschen Kontraktur im Stadium I. Therapiewoche 31:6337–6338
Keilholz L, Seegenschmiedt MH, Sauer R (1996) Radiotherapy in early stage Dupuytren’s contracture: Initial and longterm results. Int J Radiat Oncol Biol Phys 36:891–897
Keilholz L, Seegenschmiedt MH, Born AD, Sauer R (1997) Radiotherapy in the early stage of Dupuytren’s disease: The indications, technic and long-term results. Strahlenther Onkol 173:27–35
Köhler AH (1984) Die Strahlentherapie der Dupuytrenschen Kontraktur. Radiobiol Radiother 25:851–853
Lukacs S, Braun Falco O, Goldschmidt H (1978) Radiotherapy of benign dermatoses: indications, practice and results. J Dermatol Surg Oncol 4:620–625
Micke O, Seegenschmiedt MH (2002) The German Working Group guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 52:496–513
Seegenschmiedt MH, Olschewski T, Guntrum F (2001) Radiotherapy optimization in early-stage Dupuytren’s contracture: first results of a randomized clinical study. Int J Radiat Oncol Biol Phys 49:785–798
Vogt HJ, Hochschau L (1980) Behandlung der Dupuytrenschen Kontraktur. Münch Med Wschr 122:125–130
Wasserburger K (1956) Zur Therapie der Dupuytrenschen Kontraktur. Strahlentherapie 100:546–560
Zu Keloide und hypertrophe Nar
Borok TL, Bray M, Sinclair I et al. (1988) Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys 15:865–870
Cosman B, Crikelair GF, Gaulin J et al. (1961) The surgical treatment of keloids. Plast Reconstr Surg 27:335–337
Doornbos JF, Stoffel TJ, Hass AC et al. (1990) The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys 18:833–839
Emhamre A, Hammar H (1983) Treatment of keloids with postoperative X-ray irradiation. Dermatologica 167:90
Escarmant P, Zimmermann S, Amar A et al. (1993) The treatment of 783 keloid scars by Iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys 26:245–251
Guix B, Henriquez I, Andres A et al. (2001) Treatment of keloids by high-dose-rate brachytherapy: a seven-year-study. Int J Radiat Oncol Biol Phys 50:167–172
Inalsingh CHA (1974) An experience in treating five hundred and one patients with keloids. Johns Hopkins Med J 134:284–286
Janssen de Limpens MP (1986) Comparison of the treatment of keloids and hypertrophic scars. Eur J Plast Surg 9:18–21
Kovalic JJ, Perez CA (1989) Radiation therapy following keloidectomy: A 20-year experience. Int J Radiat Oncol Biol Phys 17:77–80
Lo TCM, Seckel BR, Salzman FA, Wright KA (1990) Single-dose electron beam irradiation in treatment and prevention of keloids and hypertrophic scars. Radiother Oncol 19:267–272
Micke O, Seegenschmiedt MH (2002) The German Working Group guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 52:496–513
Ollstein RN, Siegel HW, Gillooley JF et al. (1981) Treatment of keloids by combined surgical excision and immediate postoperative X-ray therapy. Ann Plast Surg 7:281–283
Prott FJ, Micke O, Wagner W, Schäfer U, Haverkamp, Willich N (1997) Narbenkeloidprophylaxe durch Bestrahlung mit Strontium-90. MTA 12:425–428
Roesler HP, Zapf S, Kuffner HD, Wissen-Siegert I, Kutzner J (1993) Strahlentherapie beim Narbenkeloid. Fortschritte der Medizin 111:46–49
Sallstrom KO, Larson O, Heden P et al. (1989) Treatment of keloids with surgical excision and postoperative X-ray radiation. Scand J Plast Reconstr Surg Hand Surg 23:211–214
Zu Sonstige Erkrankungen an Bindegewebe und Haut sowie Hautanhangsgebilden
Alafthan O, Holsti LR (1969) Prevention of Gynecomastia by local roentgen irradiation in estrogen treated prostatic carcinomas. Scand J Urol Nephrol 3:183–186
Amer M, Diab N, Ramadan A et al. (1988) Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts. J Am Acad Dermatol 18:1313–1316
Bunney MH, Nolan MW, Buxton DK et al. (1984) The treatment of resistant warts with intralesional bleomycin: A controlled clinical trial. Br J Dermatol 111:197–199
Chou JL, Easley JD, Feldmeier JJ (1988) Effective radiotherapy in palliating mammalgia associated with Gynecomastia after DES therapy. Int J Radiat Oncol Biol Phys 15:749–751
Coskey RJ (1984) Treatment of plantar warts in children with a salicylic acid-podophyllin-cantharidin product. Pediatr Dermatl 2:71–73
Fröhlich D, Baaske D, Glatzel M (2000) Radiotherapy of hidradenitis suppurativa – still valid today? Strahlenther Onkol 176:286–289
Hassenstein E (1986) Die Strahlenbehandlung gutartiger Erkrankungen – Indikationen, Ergebnisse und Technik. Röntgenblätter 39:21–23
Manusco JE, Abramow SP, Dimichino BR et al. (1991) Carbon dioxide laser management of plantar verruca: A 6-year follow-up survey. J Foot Surg 30:238–240
Metzger H, Junker A, Voss AC (1980) Die Bestrahlung der Brustdrüsen als Prophylaxe der östrogen-induzierten Gynäkomastie beim Prostatakarzinom. Strahlenther Onkol 156:102–104
Seegenschmiedt MH, Katalinic A, Makoski H et al. (2000) Radiation therapy for benign diseases: patterns of care study in Germany. Int J Radiat Oncol Biol Phys 47:195–202
Wolf H, Madson PO, Vermund H (1969) Prevention of estrogeninduced Gynecomastia by external irradiation. J Urol 102:607–609
Zu Heterotope Ossifikationen
Ahrengart L, Lindgren U (1993) Heterotopic bone after hip arthroplasty. Defining the patient at risk. Clin Orthop 293:153–159
Alberti W, Quack G, Krischke W, Lommatzsch A, Huyer C, Krahl H (1995) Verhinderung ektoper Ossifikationen nach Totalendoprothese des Hüftgelenks durch Strahlentherapie. Dtsch Med Wschr 120:983–989
Almasbakk K, Roysiand P (1977) Does indomethacin prevent postoperative ectopic ossification in total hip replacement? Acta Orthop Scand 48:556
Anthony P, Keys H, McCollister-Evarts C, Rubin P, Lush C (1987) Prevention of heterotopic bone formation with early postoperative irradiation in high risk patients undergoing total hip arthroplasty: Comparison of 10 Gy versus 20 Gy schedules. Int Radiat Oncol Biol Phys 13:365–369
Ayers DC, Evarts CM, Parkinson JR (1986) The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg 68-A:1423–1430
Ayers DC, Pellegrini VD, Evarts CM (1991) Prevention of heterotopic ossification in high-risk patients of radiation therapy. Clin Orthop 263:87–93
Bartels RH, Grotenhuis JA, Van der Spek JA (1991) Symptomatic vertebral hemangiomas. J Neurosurg Sci 35:187–192
Bijvoet OLM, Nollen AJG, Sloof TJJH, Feith R (1974) Effect of diphosphonate on para-articular ossification after total hip replacement. Acta Orthop Scand 45:926–934
Blount LH, Thomas BJ, Tran L, Selch MT, Sylvester JE, Parker RG (1990) Postoperative irradiation for prevention of heterotopic bone: analysis of different dose schedules and shielding considerations. Int J Radiat Oncol Biol Phys 19:577–581
Bosse MJ, Poka A, Reinert CM, Ellwanger F, Slawson R, Mc Devitt ER (1988) Heterotopic bone formation as a complication of acetabular fractures. J Bone Joint Surg 70-A:1231–1237
Bremnes RM, Hauge HN, Sagsveen R (1996) Radiotherapy in the treatment of symptomatic vertebral hemangiomas: Technical case report. Neurosurgery 39:1054–1058
Brooker AF, Bowerman JW, Robinson RA, Riley LH (1973) Ectopic ossification following total hip replacement. J Bone Joint Surg 55-A:1629–1632
Brunner R, Morscher E, Hünig R (1987) Paraarticular ossification in total hip replacement; An indication for irradiation therapy. Arch Orthop Trauma Surg 106:102–107
Caron JC (1976) Para articular ossification in total hip replacement. In: Geschwend N, De Brunner HV (eds) Total Hip Protheses. Bern: 171–185
Cella JP, Salvati EA, Sculco TP (1988) Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. J Arthroplasty 3:229–234
Clough JR, Price CGH (1973) Aneurysmal bone cyst: Pathogenesis and long term results of treatment. Clin Orthop 97:52–63
Conterato DJ, Verner J, Hartsell WF, Murthy AK, Galante JO, Hendrickson FR (1989) Prevention of heterotopic bone formation, comparison of 5 Gy versus 10 Gy. Int J Radiat Oncol Biol Phys 17 (Suppl 1):232
Coventry MB, Scanlon PW (1981) The use of radiation of discourage ectopic bone. A nine-year study in surgery about the hip. J Bone Joint Surg 63-A:201–208
De Flitch DJ, Stryker JA (1993) Postoperative hip irradiation in prevention of heterotopic ossification: causes of treatment failure. Radiology 188:265–270
De Lee J, Ferrari A, Charnley J (1976) Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 121:53
Doppman JL, Oldfield EH, Heiss JD (2000) Symptomatic vertebral hemangiomas: Treatment by means of direct intralesional injection of ethanol. Radiology 214:341–348
Elmstedt E, Lindholm TS, Nilsson OS, Tornkvist H (1985) Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand 56:25–27
Errico TJ, Fetto JF, Waugh TR (1984) Heterotopic ossification: Incidence and relation to trochanteric osteotomy in 100 total hip arthoplasties. Clin Orthop 190:138
Finerman GA, Stover S (1981) Ossification following hip replacement or spinal cord injury: Two clinical studies with EHDP. Met Bone Dis Relat Res 3:337–342
Fox MW, Onofrio BM (1993) The natural history and management of symptomatic and asymptomatic vertebral hemangiomas. J Neurosurg 78:36–45
Garland DE, Betzabe A, Kenneth GV, Vogt JC (1983) Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. Clin Orthop 176:197–200
Garland DE, Orwin JF (1989) Resection of heterotopic ossification in patients with spinal cord injuries. Clin Orthop 242:169–176
Garland DE (1991) A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop 263:13–29
Garland DE (1985) Resection of heterotopic ossification in the adult with head trauma. J Bone Joint Surg 67:1261–1271
Goel A, Sharp DJ (1991) Heterotopic bone formation after hip replacement. J Bone Joint Surg 73-B:255–257
Goldman AB, DiCarlo EF (1988) Pigmented villonodular synovitis. Diagnosis and differential diagnosis. Radiol Clin North Am 26/6:1327–1347
Granowitz SP, D’Antonio J, Mankin HL (1976) The pathogenesis and long-term end results of pigmented villonodular synovitis. Clin Orthop 114:335–351
Gregoritch S, Chadha M, Pellegrini V, Rubin P, Kantorowicz D (1993) Preoperative irradiation for prevention of heterotopic ossification following prothetic total hip replacement. Preliminary results. Int J Radiat Oncol Phys 27 (Suppl 1):157–158
Harrison MJ, Eisenberg MB, Ullman JS et al. (1995) Symptomatic cavernous malformations affecting the spine and spinal cord. Neurosurgery 37:195–205
Hedley AK, Leon PM, Douglas HH (1989) The prevention of heterotopic bone formation following total hip arthroplasty using 600 rad in a single dose. Arthroplasty 4:319–325
Hierton C, Blomgren G, Lindgren U (1983) Factors associated with heterotopic bone formation in cemented hip protheses. Acta Orthop Scand 54:698–702
Jasty M, Schutzer S, Tepper J, Willett C, Stracher MA, Harris WH (1990) Radiation-blocking shields to localize periarticular radiation precisely for prevention ot heterotopic bone formation around uncemented total hip arthroplasties. Clin Orthop 257:138–145
Jereb B, Smith J (1980) Giant aneurismal bone cyst of the innominate bone treated by irradiation. Br J Radiol 53:489
Kantorowitz DA, Miller GJ, Ferrara JA, Ibbott GS, Fisher R, Ahrens CR (1990) Preoperative versus postoperative irradiation in the prophylaxis of heterotopic bone formation in rats. Int J Radiat Oncol Biol Phys 19:1431–1438
Karstens JH, Gehl H-B, Sawdis E, Casser H-R, Löer F (1990) Strahlentherapie – eine wirksame Prophylaxe periartikulärer Verknöcherungen nach Implantation von Hüfttotalendoprothesen. Med Welt 41:1101–1103
Kennedy WF, Thomas AG, Chessin H, Gasparini G, Thompson W (1991) Radiation therapy to prevent heterotopic ossification after cementless total hip arthoplasty. Clin Orthop 262:185–191
Keret D, Harcke HT, Mendez AA, Bowen JR (1990) Heterotopic ossification in central nervous system-injured patients following closed nailing of femoral fractures. Clin Orthop 256:254–259
Kjaersgaard-Andersen P, Schmidt SA (1986) Indometacin for the prevention of ectopic ossification after hip arthroplasty. Acta Orth Scand 57:12–14
Kleinert H (1967) Über die Telekobalttherapie der Wirbelhämangiome. Strahlenther Onkol 134:504–510
Konski A, Pellegrini V, Poulter C, De Vanny J, Posier R, Evarts CM, Henzler M, Rubin P (1990 a) Randomized trial coaparing single dose versus fractionated Irradiation for prevention of heterotopic bone. Int Radial Oncol Biol Phys 18:1139–1142
Konski A, Weiss C, Rosier R et al. (1990 b) The use of postoperative irradiation for prevention of heterotopic bone after total hip replacement with biological fixation (porous coated) prothesis: an animal model. Int J Radiat Oncol Biol Phys 18:861–865
Laredo JD, Reizine D, Bard M et al. (1986) Vertebral hemangiomas. Radiologic evaluation. Radiology 161:183–189
Lo TC, Healy WL, Covall DJ, Dotter WE, Pfeiffer BA, Torgerson WR, Wasilewski SA (1988) Heterotopic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation. Radiology 168:851–854
Maeda M, Tateishi H, Takaiga et al. (1989) High-energy, lowdose radiation therapy for aneurismal bone cyst. Report of a case. Clin Orthop 243:200
Marcove RC, Sheth DS, Takemoto S et al. (1995) The treatment of aneurismal bone cyst. Clin Orthop 311:157
McLaren AC (1990) Prophylaxis with indomethacin for heterotopic bone. J Bone Joint Surg 72-A:245–247
McLennan I, Keys HM, Evarts CM, Rubin P (1984) Usefulness of postoperative hip irradiation in the prevention of bone formation in a high risk group of patients. Int J Radiat Oncol Biol Phys 10:49–53
McAllister VL, Kendall BE, Bull JWD (1975) Symptomatic vertebral hemangiomas. Brain 98:71–80
Metzenroth H, Publig W, Knahr K, Zandl C, Kuchner G, Carda C (1991) Ossifikationsprophylaxe nach Hüfttotalendoprothesen mit Indomethacin und ihr Einfluss auf die Magenschleimhaut. Z Orthop 129:178–182
Nobler MP, Higinbotham ML, Phillips RF (1968) The cure of aneurismal bone cyst. Irradiation superior to surgery in analysis of 33 cases. Radiology 90:1185
ÓSullivan B, Cummings B, Catton C et al. (1995) Outcome following radiation treatment for high-risk pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys 32:777–786
Orzel JA, Rudd TG (1985) Heterotopic bone formation: Clinical laboratory and imaging correlation. J Nucl Med 26:125
Padovani R, Acciarri N, Giulioni M et al. (1997) Cavernous angiomas of the spinal district: Surgical treatment of 11 patients. Eur Spine J 6:298–303
Pastushyn AI, Slinko EI, Mirzoyeva GM (1998) Vertebral hemangiomas: Diagnosis, management, natural history and clinicopathological correlates in 86 patients. Surg Neurol 50:535–547
Pedersen NW, Kristensen SS, Schmidt SA, Pedersen P, Kjaersgaard-Andersen P (1989) Factors associated with heterotopic bone formation following total hip replacement. Arch Orthop Trauma Surg 108:92–95
Plasmans CMC, Kuypers WM, Slooff TJHH (1978) The effect of ethane-1-hydroxyl-1, 1-diphosphonic acid (EHDP) on matrix induced ectopic bone formation. Clin Orthop 132:233–243
Prakash V, Lin MS, Perkash I (1978) Detection of heterotopic calcification with tc-pyrophosphate in spinal cord injury patients. Clin Nucl Med 3:167–169
Raco A, Ciappetta P, Artico M et al. (1990) Vertebral hemangiomas with cord compression: The role of embolization in five cases. Surg Neurol 34:164–168
Rades D, Bajrovic A, Alberti A, Rudat V (2002) Is there a doseeffect relationship for the treatment of symptomatic vertebral hemangioma? In: Int J Radiat Oncol Biol Phys 55:178–181
Riegler HF, Harris CM (1976) Heterotopic bone formation after total hip arthroplasty. Clin Orthop 117:209
Ritter MA, Sieber JM (1985) Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop 196:217–225
Ritter MA, Vaughan RB (1977) Ectopic ossifications after total hip arthroplasty; predisposing factors, frequency and effect on results. J Bone Joint Surg 59 A:345–351
Russell RCG, Fleisch H (1975) Pyrophosphate and diphosphonate in skeletal metabolism. Clin Orthop 108:241–263
Sauer R, Seegenschmiedt MH, Goldmann A, Beck H, Andreas P (1992) Prophylaxe periartikulärer Verknöcherungen nach endoprothetischem Hüftgelenksersatz durch postoperative Bestrahlung. Strahlenth Onkol 168:89–99
Sautter-Bihl ML, Liebermeister E, Heinze HG et al. (1995) The radiotherapy of heterotopic ossifications in para-plegics. The preliminary results. Strahlenther Onkol 171:454–459
Schmidt SA, Kjaersgaard-Andersen P, Pedersen NW, Kristensen SS, Pedersen P, Nielsen JB (1988) The use of Indomethacin to prevent the formation of heterotopic bone after total hip replacement. J Bone Joint Surg 70 A:834–838
Seegenschmiedt MH, Goldmann AR, Wölfel R, Hohmann D, Beck H, Sauer R (1993 a) Prevention of heterotopic ossification (HO) after total hip replacement: randomized high versus low dose radiotherapy. Radioth Oncol 26:271–274
Seegenschmiedt MH, Goldmann AR, Martus P, Wölfel R, Hohmann D, Sauer R (1993 b) Prophylactic radiation therapy for prevention of heterotopic ossification after hip arthroplasty: results in 141 high-risk hips. Radiology 188:257–264
Seegenschmiedt MH, Martus P, Goldmann AR et al. (1994) Peroperative vesus postoperative radiotherapiy for prevention of heterotopic ossification: First results of a randomised trial in high-risk patients. Int J Radiat Oncol Biol Phys 30:63–73
Seegenschmiedt MH, Keilholz L, Martus P, Goldmann A, Wölfel R, Henning F, Sauer R (1997) Prevention of heterotopic ossification about the hip: Final Results of two ran-domised trials in 410 patients using either preoperative or postoperative radiation therapy. Int J Radiat Oncol Biol Phys 39:161–171
Seegenschmiedt MH, Makoski H-Br, Micke O, German Cooperative Group Radiotherapy for Benign Diseases (2001) Benign Diseases: Radiation prophylaxis for heterotopic ossification about the hip joint – a multi-center study. Int J Radiat Oncol Biol Phys 51:756–765
Slawson RG, Poka A, Bathon H, Salazar O, Bromback RJ, Burgess AR (1989) The role of post operative radiation in the prevention of hetrotopic ossification in patients with posttraumatic acetabular fracture. Int J Radiat Oncol Biol Phys 17:669–672
Sodemann B, Persson PE, Nilsson OS (1988) Prevention of heterotopic ossification by non-steroid anti-inflammatory drugs after total hip arthroplasty. Clin Orthop 237:158–237
Sylvester JE, Greenberg P, Selch MT, Thomas BJ, Amstutz H (1988) The use of postoperative irradiation for the prevention of heterotopic bone formation after total hip replacement. Int J Radiat Oncol Biol Phys 14:471–476
Thomas BJ, Amstutz HC (1985) Results of administration of diphosphonate for prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg 67-A:400–403
Tonna EA, Cronkite EF (1961) Autoradiographic studies of cell proliferation in the periosteum of intact and fractured femora of mice utilizing DNA-labeling with H-3 thymidine. Proc Soc Exp Biol Med107:719–721
Unni KK, Ivins JC, Beabout JW et al. (1971) Hemangioma, hemangiopericytoma and hemangioendothelioma (angiosarcoma) of bone. Cancer 27:1403–1414
Van der Werf GJIM, van Hasselt NGM, Tonino AJ (1985) Radiotherapy in the prevention of recurrence of paraarticular ossification in total hip prosthesis. Arch Orthop Trauma Surg 104:85–88
Winkler C, Dornfeld S, Baumann M et al. (1996) Effizienz der Strahlentherapie bei Wirbelhämangiomen. Strahlenther Onkol 172:681–684
Wise MW 3d, Robertson ID, Lachiewicz PF et al. (1990) The effect of radiation therapy on the fixation strength of an experimental porous-coated implant in dogs. Clin Orthop 261:276–280
Wiss DA (1982) Recurrent villonodular synovitis of the knee. Successful treatment with yttrium-90. Clin Orthop Related Res 169:139–144
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Seegenschmiedt, M. (2013). Nichtmaligne Erkrankungen. In: Wannenmacher, M., Wenz, F., Debus, J. (eds) Strahlentherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-88305-0_36
Download citation
DOI: https://doi.org/10.1007/978-3-540-88305-0_36
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-88304-3
Online ISBN: 978-3-540-88305-0
eBook Packages: Medicine (German Language)